University of Wisconsin–Madison

First Patient at UW Carbone Cancer Center Treated with Multiple Myeloma Personalized Cellular Vaccine

The first patient in a personalized multiple myeloma vaccine clinical trial at the UW Carbone Cancer Center was treated this past week. This cell-based vaccine was created at UW Health’s in-house Clinical Hematopoietic Cell Processing Laboratory (CHCPL).

Read the full article at: